VEGFR2 anticorps (Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase)) (pTyr1214)

Details for Product anti-KDR Antibody No. ABIN2687866
Antigène
  • CD309
  • FLK1
  • VEGFR
  • VEGFR2
  • 6130401C07
  • Flk-1
  • Flk1
  • Krd-1
  • Ly73
  • VEGFR-2
  • sVEGFR-2
  • Vegfr-2
  • FLK-1
  • flk-1
  • vegfr-2
  • KDR
  • FLK/KDR
  • flk1
  • flk1b
  • kdrb
  • si:busm1-205d10.1
  • si:ch211-254j6.1
  • si:ch211-278f21.4
  • wu:fc31a09
  • fk52c05
  • flk
  • kdr
  • kdra
  • vegfr2
  • vegfr4
  • vegr2
  • wu:fk52c05
  • kinase insert domain receptor
  • kinase insert domain protein receptor
  • vascular endothelial growth factor receptor kdr-like
  • kinase insert domain receptor (a type III receptor tyrosine kinase)
  • kinase insert domain receptor like
  • KDR
  • Kdr
  • LOC100136647
  • kdr
  • kdrl
Épitope
pTyr1214
66
61
49
49
29
23
19
18
16
16
15
14
13
10
9
9
8
7
7
7
7
7
7
6
6
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivité
Humain, Souris
599
356
213
27
7
5
5
4
4
2
2
2
2
2
2
2
2
2
2
1
1
1
1
Hôte
Lapin
562
118
21
2
2
1
1
1
Clonalité
Monoclonal
Conjugué
Cet anticorp VEGFR2 est non-conjugé
44
26
25
22
14
12
10
10
10
10
10
10
3
3
3
3
3
3
3
2
2
2
2
1
1
Application
Immunohistochemistry (IHC)
460
265
247
142
118
103
31
31
26
24
22
19
16
8
8
4
2
1
Options
Immunogène The antiserum was produced against synthesized phosphopeptide derived from human VEGFR2 around the phosphorylation site of tyrosine 1214 (F-H-YP-D-N).
Specificité VEGFR2 (phospho-Tyr1214) antibody detects endogenous levels of VEGFR2 only when phosphorylated at tyrosine 1214.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
Plasmids, Primers & others Plasmids, Primers & others VEGFR2 products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation VEGFR2 (KDR Antibody Extrait)
Pathways Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Indications d'application IHC: 1:50~1:100
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C,-20 °C
Avez-vous cherché autre chose?